Community mobility in Taiwan from April 1 to August 26, 2021. by Hsiao-Hui Tsou (436144)

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. by Huriye Senay Kiziltan (22298378)

Table_1_E2 Site Mutations in S Protein Strongly Affect Hepatitis B Surface Antigen Detection in the Occult Hepatitis B Virus.DOCX by Hao Wang (39217)

“…Meanwhile, for E2G/A mutations, the relative intracellular HBsAg (110.7–338.3% vs. extracellular) and its fluorescence intensity (1.5–2.4-fold vs. with genotype-matched pHBV1.3B/C) were significantly higher (p < 0.05). …”

CPA treatment lowered activated caspase 3 and GFAP levels while DPCPX increased activated Caspase 3 and GFAP levels. by Manuel Soliño (5410001)

“…F) Quantification of C3a by WB. DPCPX produced a highly significant rise in C3a relative density compared to CTL (1.85±0.5 vs 1.01±0.07; unpaired Student´s t-test; p<0.01; n = 4), **p<0.01.…”

A comprehensive study of glucose and oxygen gradients in a scaled-down model of recombinant HuGM-CSF production in thermoinduced <i>Escherichia coli</i> fed-batch cultures by Greta I. Reynoso-Cereceda (18501789)

“…</p> <p></p><p>Thermoinduced recombinant <i>E. coli</i> grew less in a two-compartment scale-down model.</p><p>Heat-inducible <i>E. coli</i> cultures at a large scale significantly decrease recombinant protein production.…”

Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity by Lydia W. S. Finley (209240)

“…</p> <h3>Methodology/Principal Findings</h3><p>In this study, we performed a proteomic screen to identify SIRT3 interacting proteins and identified several subunits of complex II and V of the electron transport chain. …”

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

<i>F. novicida</i> deletion mutants of a putative transglutaminase are severely attenuated in virulence and growth. by Madeleine G. Moule (243057)

“…The difference between the mean number of CFUs of wild-type and FTN_0869 has decreased at every timepoint, with only a 2.9-fold increase in wild-type bacteria compared to FTN_0869 bacteria at 24 hours, 6-fold more bacteria in U112 infected flies at 48 hours, and only 4-fold more U112 bacteria than FTN_0869 bacteria at 72 hours. …”

Temperature effects from a single synaptic input produce delays. by Matías A. Goldin (424331)

“…All neurons present interspike interval increases and HVC_<i>RA</i> also shows a spike onset delay with decreasing temperatures. …”

Table_1_Adaptive Homeostatic Strategies of Resilient Intrinsic Self-Regulation in Extremes (RISE): A Randomized Controlled Trial of a Novel Behavioral Treatment for Chronic Pain.do... by Martha Kent (4776228)

“…<p>Current treatments for chronic pain have limited benefit. We describe a resilience intervention for individuals with chronic pain which is based on a model of viewing chronic pain as dysregulated homeostasis and which seeks to restore homeostatic self-regulation using strategies exemplified by survivors of extreme environments. …”

Analysis of glycine and proliferation <i>in vitro</i> as a function of SHMT2 and sodium benzoate. by Jiefei Tong (426705)

“…Intracellular metabolites were extracted and analyzed by selected reaction monitoring mass spectrometry, SRM, n = 5 to 8 biological replicates. (A) In HeLa-Ss cells relative levels of intracellular glycine levels were measured as a function of endogenous SHMT2 expression (control; C) or elevated (+) or decreased (–) expression of SHTM2 (described above), and without (–) or with (+) glycine supplementation in growth medium. …”

VEGF immunoperoxidase in kidneys of 17-GD LP progeny compared to NP offspring. by Julia Seva Gomes (15411772)

HIF-1α immunoperoxidase in kidneys of 17-GD LP progeny compared to NP offspring. by Julia Seva Gomes (15411772)